139 related articles for article (PubMed ID: 26581002)
21. Hereditary non-medullary thyroid cancer.
Kebebew E
World J Surg; 2008 May; 32(5):678-82. PubMed ID: 18058169
[TBL] [Abstract][Full Text] [Related]
22. [Hereditary thyroid carcinoma and its molecular diagnostics].
Dvořáková S; Václavíková E; Sýkorová V; Hálková T; Bendlová B
Cesk Patol; 2014 Apr; 50(2):81-6. PubMed ID: 24758503
[TBL] [Abstract][Full Text] [Related]
23. The G534E variant in HABP2 is not associated with increased risk of familial nonmedullary thyroid cancer in Brazilian Kindreds.
de Mello LEB; Araujo AN; Alves CX; de Paiva FJP; Brandão-Neto J; Cerutti JM
Clin Endocrinol (Oxf); 2017 Jul; 87(1):113-114. PubMed ID: 28418605
[No Abstract] [Full Text] [Related]
24. Prophylactic thyroidectomy: who needs it, when, and why.
Wang TS; Opoku-Boateng A; Roman SA; Sosa JA
J Surg Oncol; 2015 Jan; 111(1):61-5. PubMed ID: 24965542
[TBL] [Abstract][Full Text] [Related]
25. Thyroid cancer of follicular cell origin in inherited tumor syndromes.
Nosé V
Adv Anat Pathol; 2010 Nov; 17(6):428-36. PubMed ID: 20966648
[TBL] [Abstract][Full Text] [Related]
26. Parathyroid adenoma and nonmedullary thyroid carcinoma association.
Simpson RJ; Moss J
Otolaryngol Head Neck Surg; 1989 Nov; 101(5):584-7. PubMed ID: 2574436
[No Abstract] [Full Text] [Related]
27. Genetic mutations in thyroid carcinoma.
Taccaliti A; Boscaro M
Minerva Endocrinol; 2009 Mar; 34(1):11-28. PubMed ID: 19209125
[TBL] [Abstract][Full Text] [Related]
28. The thyrotropin receptor in thyroid diseases.
Paschke R; Ludgate M
N Engl J Med; 1997 Dec; 337(23):1675-81. PubMed ID: 9385128
[No Abstract] [Full Text] [Related]
29. Prognostic impact of germline mutations in inherited cancer syndromes.
Corso G; Feroce I; Intra M; Veronesi P; Sacchini V; Bonanni B; Galimberti V
Future Oncol; 2017 Oct; 13(24):2125-2127. PubMed ID: 28984488
[No Abstract] [Full Text] [Related]
30. A case of Muir-Torre syndrome associated with mucinous hepatic cholangiocarcinoma and a novel germline mutation of the MSH2 gene.
Vernez M; Hutter P; Monnerat C; Halkic N; Gugerli O; Bouzourene H
Fam Cancer; 2007; 6(1):141-5. PubMed ID: 17051350
[TBL] [Abstract][Full Text] [Related]
31. Pitfalls of Personalizing Cancer Treatment.
Perez K
Am J Clin Oncol; 2016 Feb; 39(1):107. PubMed ID: 26785382
[No Abstract] [Full Text] [Related]
32. Functional characterization of the MTC-associated germline RET-K666E mutation: evidence of oncogenic potential enhanced by the G691S polymorphism.
Borrello MG; Aiello A; Peissel B; Rizzetti MG; Mondellini P; Degl'Innocenti D; Catalano V; Gobbo M; Collini P; Bongarzone I; Pierotti MA; Greco A; Seregni E
Endocr Relat Cancer; 2011 Aug; 18(4):519-27. PubMed ID: 21690267
[TBL] [Abstract][Full Text] [Related]
33. The T1799A BRAF mutation is not a germline mutation in familial nonmedullary thyroid cancer.
Xing M
Clin Endocrinol (Oxf); 2005 Sep; 63(3):263-6. PubMed ID: 16117812
[TBL] [Abstract][Full Text] [Related]
34. Familial thyroid neoplasia: impact of technological advances on detection and monitoring.
Tran T; Gianoukakis AG
Curr Opin Endocrinol Diabetes Obes; 2010 Oct; 17(5):425-31. PubMed ID: 20729730
[TBL] [Abstract][Full Text] [Related]
35. Surveillance of patients with hereditary gastrointestinal cancer syndromes.
Moreira L; Castells A
Best Pract Res Clin Gastroenterol; 2016 Dec; 30(6):923-935. PubMed ID: 27938787
[TBL] [Abstract][Full Text] [Related]
36. Papillary thyroid carcinoma: 6 cases from 2 families with associated lymphocytic thyroiditis harbouring RET/PTC rearrangements.
Mechler C; Bounacer A; Suarez H; Saint Frison M; Magois C; Aillet G; Gaulier A
Br J Cancer; 2001 Dec; 85(12):1831-7. PubMed ID: 11747322
[TBL] [Abstract][Full Text] [Related]
37. Very early manifestation of hereditary medullary thyroid cancer in carriers of intracellular-domain RET mutations.
Machens A; Dralle H
J Pediatr Surg; 2007 Jun; 42(6):1153; author reply 1154. PubMed ID: 17560241
[No Abstract] [Full Text] [Related]
38. Mendelian genetics of rare--and not so rare--cancers.
Eng C
Ann N Y Acad Sci; 2010 Dec; 1214():70-82. PubMed ID: 20946573
[TBL] [Abstract][Full Text] [Related]
39. A comprehensive analysis of MNG1, TCO1, fPTC, PTEN, TSHR, and TRKA in familial nonmedullary thyroid cancer: confirmation of linkage to TCO1.
Bevan S; Pal T; Greenberg CR; Green H; Wixey J; Bignell G; Narod SA; Foulkes WD; Stratton MR; Houlston RS
J Clin Endocrinol Metab; 2001 Aug; 86(8):3701-4. PubMed ID: 11502798
[TBL] [Abstract][Full Text] [Related]
40. Histology of familial thyroid tumours linked to a gene mapping to chromosome 19p13.2.
Harach HR; Lesueur F; Amati P; Brown A; Canzian F; Kraimps JL; Levillain P; Menet E; Romeo G; Bonneau D
J Pathol; 1999 Nov; 189(3):387-93. PubMed ID: 10547601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
